title: Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project.
abstract: To assess the relationship between the within-host diversity of malaria infections and the susceptibility of the host to subsequent infection, we genotyped 60 children's successive infections from birth through 3 years of life. MSP-1 Block2 genotypes were used to estimate the complexity of infection (COI). Malaria transmission and age were positively associated with the number of K1 and Mad20 alleles detected (COI(KM)) (P < 0.003). Controlling for previous parasitemia, transmission, drug treatment, parasite density, sickle cell, and age, COI(KM) was negatively correlated with resistance to parasitemia of > 500/microl (P < 0.0001). Parasitemias with the RO-genotype were more resistant than those without this genotype (P < 0.0000). The resistance in low COI(KM) infections was not genotype specific. We discuss the impact of genotype-transcending immunity to conserved antigenic determinants. We also propose a diversity-driven immunomodulation hypothesis that may explain the delayed development of natural immunity in the first few years of life and suggest that interventions that decrease the COI(KM) could facilitate the development of protective immunity.
authors.affiliation: Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
authors.forename: O H
authors.initials: OH
authors.lastname: Branch
authors.forename: S
authors.initials: S
authors.lastname: Takala
authors.forename: S
authors.initials: S
authors.lastname: Kariuki
authors.forename: B L
authors.initials: BL
authors.lastname: Nahlen
authors.forename: M
authors.initials: M
authors.lastname: Kolczak
authors.forename: W
authors.initials: W
authors.lastname: Hawley
authors.forename: A A
authors.initials: AA
authors.lastname: Lal
mesh_terms: D000328:Adult; D000367:Age Factors; D000818:Animals; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D005838:Genotype; D006801:Humans; D007110:Immunity, Active; D007113:Immunity, Innate; D007223:Infant; D007231:Infant, Newborn; D007630:Kenya / Q000453:epidemiology; D016778:Malaria, Falciparum / Q000097:blood / Q000453:epidemiology / Q000276:immunology*; D008297:Male; D020066:Merozoite Surface Protein 1 / Q000235:genetics*; D018512:Parasitemia / Q000453:epidemiology / Q000276:immunology; D010963:Plasmodium falciparum / Q000235:genetics*; D011247:Pregnancy
chemical_list: D020066:Merozoite Surface Protein 1